By: Elizabeth Catherine Smyth – Cambridge University Hospitals NHS Foundation Trust Background: Oesophagogastric adenocarcinoma (OGA) remains a significant global health…
Browsing: ascogi
Background: The treatment landscape for well-differentiated gastroenteropancreatic neuroendocrine tumors (GEP-NETs) has been slow to evolve, with limited evidence supporting the…
OncologyTube: [00:00:00] Okay, here we are at ASCO GI 2024. We have Dominik Paul Modest, MD medical doctor from Charite,University…